|
|
 |
Investment Portfolio
Athenix
Athenix is a leading biotechnology company that discovers and develops novel products, technologies and processes for the agricultural and chemical businesses.
The company provides genes, proteins, traits, and transgenic organisms for multiple industry sectors including seed, agricultural chemicals, specialty chemicals, industrial enzymes, energy and feed.
For the official press release and news on Finistere's role in the latest investment round, see www.newsobserver.com/104/story/385430.html
Athenix is located in Durham, North Carolina, US.
Bioabsorbable Therapeutics, Inc
Bioabsorbable Therapeutics, Inc. ("BTI") is developing a novel bioabsorbable polymer stent platform that will be used for the treatment of coronary vascular disease.
For the official press release and news on Finistere Venture's role in the $9MM Series B funding round, click here.
BTI is located in Menlo Park, California, US.
Catharos Medical Systems
Catharos is an early stage medical device company that is focused on preventing contrast induced nephropathy ("CIN") by removing radio-contrast dye injected during catheterizations from the patient's body prior to the dye reaching the kidneys.
Catharos is based in Los Gatos, California, US.
Chlorogen
Chlorogen aims to be a world-class provider of beneficial proteins and antibodies for human therapy. Chlorogen is committed to developing plant-made drugs and vaccines for the treatment and prevention of human diseases. Chlorogen is the leader in chloroplast transformation technology, which promises to be the future of protein production in plants.
Chlorogen is located in St Louis, Missouri, US.
Hawaii Bio Energy
Hawaii Bio Energy, LLC ("HBE") is an international consortium led by three of Hawaii's largest landowners - Grove Farm Company, Maui Land and Pineapple Inc., and Kamehameha Schools. HBE is actively researching sugarcane and other potential fuel crops, processing techniques, and distribution channels for the production of renewable bio-fuels within Hawaii. In addition to Finistere Ventures, its other investor partners also include renewable fuel industry leaders Khosla Ventures.
Hawaii Bio Energy is located in Honolulu, Oahu, US.
For the official press release and news on Finistere's role in the latest investment round, click here.
For more about Hawaii Bio Energy, click here to read the New York Times article.
Luminous Medical, Inc
Luminous Medical is developing an automated glucose measurement system that addresses the rapidly growing clinical demand for tight glycemic control ("TGC") in the intensive care unit, operating room and intermediate care units.
For the official press release and news on Finistere's role in the latest investment round, see www.luminousmedical.com/news.html
Luminous is located in Carlsbad, CA.
nContact Surgical Inc
nContact Surgical is an early stage medical device company focused on providing new tissue coagulation devices used during surgical procedures for the treatment of atrial fibrilation.
nContact is located in Morrisville, North Carolina, US.
Sadra Medical Inc
Sadra Medical is developing innovative percutaneous therapies for the treatment of aortic valve disease that will provide a less invasive alternative to traditional surgical valve replacement.
Sadra is located in Campbell, California, US.
SquareOne Inc
SquareOne is a development stage medical device company focused on developing and commercializing innovative, ostial stenting solutions.
SquareOne is located in Campbell, California, US.
